NanoVibronix (Nasdaq:NAOV) announced today that it completed the first phase of a randomized controlled trial for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback